Market revenue in 2021 | USD 764.6 million |
Market revenue in 2030 | USD 1,684.3 million |
Growth rate | 9.2% (CAGR from 2021 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Preclinical |
Historical data covered | 2018 - 2020 |
Base year for estimation | 2021 |
Forecast period covered | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preclinical, Clinical |
Key market players worldwide | Labcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Toxikon, Intertek Group PLC, Pace Analytical Services, Icon PLC, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to large molecule bioanalytical testing services market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 66.14% in 2021. Horizon Databook has segmented the North America large molecule bioanalytical testing services market based on preclinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
North America dominated the global market for bioanalytical testing services in 2020 because it is among the top manufacturing hubs for highly reliable, complex, and high-end pharmaceuticals. Rapid technological advancements and growing demand for bioanalytical testing services are factors expected to drive the global large molecule bioanalytical testing services market.
Moreover, biopharmaceutical companies are focusing on the U.S. market due to the booming healthcare industry in the country. Increasing investments by bioanalytical testing services organizations, growing R&D spending in the biopharmaceutical industry, and favorable regulatory reforms are factors contributing to growth of the large molecule bioanalytical testing services market.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America large molecule bioanalytical testing services market , including forecasts for subscribers. This continent databook contains high-level insights into North America large molecule bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account